ALK-Abelló A/S (ALK-B) - Net Assets

Latest as of December 2025: Dkr6.45 Billion DKK ≈ $1.01 Billion USD

Based on the latest financial reports, ALK-Abelló A/S (ALK-B) has net assets worth Dkr6.45 Billion DKK (≈ $1.01 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr9.17 Billion ≈ $1.44 Billion USD) and total liabilities (Dkr2.73 Billion ≈ $426.66 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of ALK-Abelló A/S to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Dkr6.45 Billion
% of Total Assets	70.27%
Annual Growth Rate	0.19%
5-Year Change	85.2%
10-Year Change	124.17%
Growth Volatility	17.72

ALK-Abelló A/S - Net Assets Trend (2005–2025)

This chart illustrates how ALK-Abelló A/S's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of ALK-Abelló A/S for the complete picture of this company's asset base.

Annual Net Assets for ALK-Abelló A/S (2005–2025)

The table below shows the annual net assets of ALK-Abelló A/S from 2005 to 2025. For live valuation and market cap data, see ALK-B market cap.

Year	Net Assets	Change
2025-12-31	Dkr6.45 Billion ≈ $1.01 Billion	+19.95%
2024-12-31	Dkr5.37 Billion ≈ $840.64 Million	+20.82%
2023-12-31	Dkr4.45 Billion ≈ $695.77 Million	+11.51%
2022-12-31	Dkr3.99 Billion ≈ $623.95 Million	+14.60%
2021-12-31	Dkr3.48 Billion ≈ $544.47 Million	+10.37%
2020-12-31	Dkr3.15 Billion ≈ $493.31 Million	-0.72%
2019-12-31	Dkr3.18 Billion ≈ $496.91 Million	-0.09%
2018-12-31	Dkr3.18 Billion ≈ $497.38 Million	-3.37%
2017-12-31	Dkr3.29 Billion ≈ $514.74 Million	+14.43%
2016-12-31	Dkr2.88 Billion ≈ $449.81 Million	+6.60%
2015-12-31	Dkr2.70 Billion ≈ $421.97 Million	+14.57%
2014-12-31	Dkr2.35 Billion ≈ $368.30 Million	+4.67%
2013-12-31	Dkr2.25 Billion ≈ $351.87 Million	-1.53%
2012-12-31	Dkr2.28 Billion ≈ $357.35 Million	+5.40%
2011-12-31	Dkr2.17 Billion ≈ $339.04 Million	+7.38%
2010-12-31	Dkr2.02 Billion ≈ $315.73 Million	+4.67%
2009-12-31	Dkr1.93 Billion ≈ $301.65 Million	+3.54%
2008-12-31	Dkr1.86 Billion ≈ $291.32 Million	-11.84%
2007-12-31	Dkr2.11 Billion ≈ $330.44 Million	+0.86%
2006-12-31	Dkr2.09 Billion ≈ $327.62 Million	-66.27%
2005-12-31	Dkr6.21 Billion ≈ $971.29 Million	--

Equity Component Analysis

This analysis shows how different components contribute to ALK-Abelló A/S's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 608200000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	Dkr6.08 Billion	94.37%
Common Stock	Dkr111.00 Million	1.72%
Other Comprehensive Income	Dkr252.00 Million	3.91%
Total Equity	Dkr6.45 Billion	100.00%

ALK-Abelló A/S Competitors by Market Cap

The table below lists competitors of ALK-Abelló A/S ranked by their market capitalization.

Company	Market Cap
Inpost SA AS:INPST	$7.62 Billion
The Federal Bank Limited NSE:FEDERALBNK	$7.63 Billion
Planet Labs PBC NYSE:PL	$7.65 Billion
BYD Electronic (International) Company Limited F:4BY	$7.65 Billion
Commercial Metals Company NYSE:CMC	$7.61 Billion
Thai Beverage Public Company Limited F:T6W	$7.61 Billion
Shenzhen Capchem Tech SHE:300037	$7.60 Billion
UGI Corporation NYSE:UGI	$7.60 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ALK-Abelló A/S's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 5,373,000,000 to 6,445,000,000, a change of 1,072,000,000 (20.0%).
Net income of 1,197,000,000 contributed positively to equity growth.
Other comprehensive income increased equity by 187,000,000.
Other factors decreased equity by 312,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Dkr1.20 Billion	+18.57%
Other Comprehensive Income	Dkr187.00 Million	+2.9%
Other Changes	Dkr-312.00 Million	-4.84%
Total Change	Dkr-	19.95%

Book Value vs Market Value Analysis

This analysis compares ALK-Abelló A/S's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 8.33x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 7.88x to 8.33x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-12-31	Dkr30.70	Dkr242.00	x
2006-12-31	Dkr10.36	Dkr242.00	x
2007-12-31	Dkr10.49	Dkr242.00	x
2008-12-31	Dkr9.32	Dkr242.00	x
2009-12-31	Dkr9.68	Dkr242.00	x
2010-12-31	Dkr10.18	Dkr242.00	x
2011-12-31	Dkr10.95	Dkr242.00	x
2012-12-31	Dkr11.67	Dkr242.00	x
2013-12-31	Dkr11.50	Dkr242.00	x
2014-12-31	Dkr11.92	Dkr242.00	x
2015-12-31	Dkr13.70	Dkr242.00	x
2016-12-31	Dkr14.50	Dkr242.00	x
2017-12-31	Dkr16.51	Dkr242.00	x
2018-12-31	Dkr14.57	Dkr242.00	x
2019-12-31	Dkr14.57	Dkr242.00	x
2020-12-31	Dkr14.34	Dkr242.00	x
2021-12-31	Dkr15.75	Dkr242.00	x
2022-12-31	Dkr18.01	Dkr242.00	x
2023-12-31	Dkr20.10	Dkr242.00	x
2024-12-31	Dkr24.25	Dkr242.00	x
2025-12-31	Dkr29.06	Dkr242.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently ALK-Abelló A/S utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 18.57%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 18.96%
• Asset Turnover: 0.69x
• Equity Multiplier: 1.42x
Recent ROE (18.57%) is above the historical average (9.34%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	69.69%	353.49%	0.18x	1.12x	Dkr3.68 Billion
2006	1.15%	1.61%	0.53x	1.33x	Dkr-185.40 Million
2007	8.38%	10.71%	0.59x	1.34x	Dkr-34.20 Million
2008	5.10%	5.33%	0.70x	1.36x	Dkr-91.20 Million
2009	6.12%	6.10%	0.73x	1.38x	Dkr-74.80 Million
2010	6.34%	5.93%	0.76x	1.40x	Dkr-73.80 Million
2011	9.23%	8.52%	0.70x	1.55x	Dkr-16.70 Million
2012	9.15%	8.91%	0.71x	1.44x	Dkr-19.40 Million
2013	2.71%	2.72%	0.69x	1.45x	Dkr-163.90 Million
2014	7.69%	7.44%	0.71x	1.45x	Dkr-54.40 Million
2015	12.75%	13.39%	0.60x	1.58x	Dkr74.30 Million
2016	9.39%	8.99%	0.63x	1.67x	Dkr-17.50 Million
2017	-4.80%	-5.43%	0.59x	1.51x	Dkr-487.00 Million
2018	-5.35%	-5.83%	0.60x	1.53x	Dkr-487.90 Million
2019	-1.57%	-1.53%	0.60x	1.73x	Dkr-367.60 Million
2020	0.79%	0.72%	0.63x	1.76x	Dkr-290.30 Million
2021	6.29%	5.59%	0.67x	1.68x	Dkr-129.00 Million
2022	8.40%	7.43%	0.72x	1.58x	Dkr-63.80 Million
2023	10.93%	10.07%	0.72x	1.51x	Dkr41.30 Million
2024	15.17%	14.72%	0.67x	1.53x	Dkr277.70 Million
2025	18.57%	18.96%	0.69x	1.42x	Dkr552.50 Million

Industry Comparison

This section compares ALK-Abelló A/S's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $557,639,600
Average return on equity (ROE) among peers: -33.01%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
ALK-Abelló A/S (ALK-B)	Dkr6.45 Billion	69.69%	0.42x	$7.62 Billion
Bavarian Nordic (BAVA)	$1.02 Billion	-21.30%	0.67x	$2.30 Billion
Genmab A/S (GMAB)	$659.52 Million	17.04%	1.63x	$16.33 Billion
Gubra A/S (GUBRA)	$151.46 Million	44.85%	0.99x	$820.85 Million
Pharma Equity Group A/S Cl A (PEG)	$34.28 Million	-95.90%	0.68x	$16.36 Million
Zealand Pharma A/S (ZEAL)	$927.80 Million	-109.74%	1.23x	$3.41 Billion

About ALK-Abelló A/S

CO:ALK-B Denmark Biotechnology

Market Cap

$7.62 Billion

Dkr48.72 Billion DKK

Market Cap Rank

#2704 Global

#15 in Denmark

Share Price

Dkr242.00

Change (1 day)

+1.51%

52-Week Range

Dkr159.00 - Dkr242.00

All Time High

Dkr242.00